Zand Khashayar Rafat, Reinhold Caroline, Abe Hisashi, Maheshwari Sharad, Mohamed Ahmed, Upegui Daniel
Department of Radiology, McGill University Health Center, Montreal, QC, Canada.
Cancer Imaging. 2007 May 28;7(1):69-76. doi: 10.1102/1470-7330.2007.0011.
Due to deficiencies of clinical staging, magnetic resonance (MR) imaging is being increasingly used in the pre-treatment work-up of cervical cancer. Lymph node status, as evaluated by advanced imaging modalities, is also being incorporated into management algorithms. Familiarity with MR imaging features will lead to more accurate staging of cervical cancer. Awareness of impact of staging on management will enable the radiologists to tailor the report to clinically and surgically relevant information. This article emphasizes the guidelines on the MR staging criteria, dependence of newer treatments on imaging staging and lymph node involvement, and MR imaging in post-treatment surveillance of cervical cancer.
由于临床分期存在不足，磁共振（MR）成像在宫颈癌的治疗前检查中越来越多地被使用。通过先进成像方式评估的淋巴结状态也被纳入管理算法中。熟悉MR成像特征将有助于更准确地对宫颈癌进行分期。了解分期对治疗管理的影响将使放射科医生能够根据临床和手术相关信息来撰写报告。本文重点介绍了MR分期标准的指南、新治疗方法对成像分期和淋巴结受累情况的依赖性以及宫颈癌治疗后监测中的MR成像。
